Fund Holdings — Casdin Capital, LLC

Total Portfolio Value:
$1.61B
Total Bought:
$241.13M
Total Sold:
$157.24M
Net Transaction:
+$83.89M
Notable People:
Eli D Casdin, Lawrence Jude Canzoneri, Alexandria Fisk, Angelo Crupi, Steven Michael Giordano
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
GeneDx Holdings Corp.CL A(WGS)3,007,1643,007,1640$323.99M$391.11M24.29%+$67.12M
Revolution Medicines, Inc.(RVMD)2,647,3332,577,333-70,000$123.63M$205.28M12.75%+$81.65M
Biolife Solutions Inc6,707,1655,957,165-750,000$171.10M$144.04M8.95%-$27.06M
Standard BioTools Inc.(LAB)77,558,85688,783,856+11,225,000$100.83M$113.64M7.06%+$12.82M
Relay Therapeutics, Inc.(RLAY)11,341,38113,003,574+1,662,193$59.20M$110.01M6.83%+$50.81M
Structure Therapeutics IncADS1,555,0001,175,000-380,000$43.54M$81.72M5.08%+$38.18M
Illumina, Inc.(ILMN)525,000600,000+75,000$49.86M$78.70M4.89%+$28.84M
Avidity Biosciences Inc1,780,0001,000,000-780,000$77.55M$72.13M4.48%-$5.42M
Beam Therapeutics Inc.(BEAM)1,600,0001,600,0000$38.83M$44.35M2.75%+$5.52M
Guardant Health, Inc.(GH)100,000380,000+280,000$6.25M$38.81M2.41%+$32.57M
Maze Therapeutics, Inc.(MAZE)758,857758,8570$19.68M$31.44M1.95%+$11.76M
Denali Therapeutics Inc.(DNLI)890,0001,840,000+950,000$12.92M$30.38M1.89%+$17.46M
Alnylam Pharmaceuticals, Inc.(ALNY)55,00075,000+20,000$25.08M$29.82M1.85%+$4.74M
Neurogene Inc.(NGNE)1,295,3611,295,3610$22.45M$26.68M1.66%+$4.24M
10x Genomics, Inc.CL A(TXG)01,400,000+1,400,000$0$22.83M1.42%+$22.83M
ARS Pharmaceuticals, Inc.(SPRY)1,600,0001,600,0000$16.08M$18.64M1.16%+$2.56M
Tempus AI, Inc.CL A(TEM)294,127294,1270$23.74M$17.37M1.08%-$6.37M
UnitedHealth Group Incorporated(UNH)25,00050,000+25,000$8.63M$16.51M1.03%+$7.87M
Septerna, Inc.(SEPN)553,268553,2680$10.41M$15.43M0.96%+$5.02M
Hims & Hers Health, Inc.CL A(HIMS)230,000385,000+155,000$13.05M$12.50M0.78%-$544.6K
Veracyte, Inc.(VCYT)276,308276,3080$9.49M$11.63M0.72%+$2.15M
DexCom, Inc.(DXCM)0175,000+175,000$0$11.61M0.72%+$11.61M
Scholar Rock Holding Corporation(SRRK)0260,000+260,000$0$11.45M0.71%+$11.45M
The Cigna Group(CI)040,000+40,000$0$11.01M0.68%+$11.01M
Prime Medicine, Inc.(PRME)3,167,1753,167,1750$17.55M$10.99M0.68%-$6.56M
Incyte Corporation(INCY)100,000100,0000$8.48M$9.88M0.61%+$1.40M
Quest Diagnostics Incorporated(DGX)050,000+50,000$0$8.68M0.54%+$8.68M
Taysha Gene Therapies, Inc.(TSHA)01,500,000+1,500,000$0$8.25M0.51%+$8.25M
Pacific Biosciences of California, Inc.(PACB)723,7674,223,767+3,500,000$926.4K$7.90M0.49%+$6.97M
Legend Biotech CorporationADS(LEGN)0215,000+215,000$0$4.67M0.29%+$4.67M
BridgeBio Oncology Therapeutics, Inc.(BBOT)282,312282,3120$3.27M$3.53M0.22%+$265.4K
Absci Corporation973,260973,2600$2.96M$3.40M0.21%+$438.0K
Contineum Therapeutics, Inc.CL A(CTNM)148,333148,3330$1.74M$1.70M0.11%-$47.5K
Monte Rosa Therapeutics, Inc.(GLUE)86,01486,0140$637.4K$1.35M0.08%+$711.3K
Century Therapeutics, Inc.(IPSC)1,228,1901,228,1900$611.6K$1.22M0.08%+$610.2K
Recursion Pharmaceuticals, Inc.CL A(RXRX)165,323165,3230$806.8K$676.2K0.04%-$130.6K
Ginkgo Bioworks Holdings, Inc.CL A(DNA)36,49336,4930$532.1K$303.3K0.02%-$228.8K
Tenaya Therapeutics, Inc.(TNYA)361,969361,9690$586.4K$257.5K0.02%-$328.8K
Endeavour Silver Corp.(EXK)90,0000-90,000$4.92M$0—-$4.92M
Page 1 of 1
Casdin Capital, LLC — 13F Holdings — Q4 2025 | TickerTrail